Table 5.
Comparison of clinical variables between pre and post treatment.
| Pre-treatment | Post-treamtment | p | |||
|---|---|---|---|---|---|
| Mean | SD | Mean | SD | ||
| VAS | 41.73 | 19.34 | 14.62 | 14.49 | <0.001** |
| UA (mg/dL) | 5.22 | 1.41 | 5.49 | 1.36 | n.s. |
| CRP (mg/dL) | 1.14 | 2.02 | 0.27 | 0.62 | <0.05* |
| MMP-3 (ng/mL) | 119.92 | 143.19 | 74.48 | 39.49 | n.s. |
| WBC (x103/mL) | 7.3 | 1.53 | 7.06 | 1.77 | n.s. |
| Plt (x103/mL) | 278.35 | 90.71 | 248.92 | 67.22 | <0.05* |
| Neu (x103/mL) | 4.67 | 1.56 | 4.09 | 1.28 | <0.05* |
| Lym (x103/mL) | 2 | 0.82 | 2.15 | 0.83 | <0.05* |
| PLR | 170.07 | 116.4 | 130.13 | 53.09 | <0.001** |
| NLR | 2.97 | 2.28 | 2.24 | 1.66 | <0.05* |
*P < 0.05 was considered statistically significant. VAS, Visual Analog Scale; UA, Uric acid; CRP, serum C-reactive protein; MMP-3, matrix metalloproteinase-3; WBC; white blood cell; Plt, Platelets; Neu, Neutrophils; Lym, Lymphocytes; PLR, platelet-lymphocyte ratio; NLR, neutrophil-lymphocyte ratio. CRP was not available in two cases.